"These grants highlight The Wertheim UF Scripps Institute’s unique expertise in areas that include neuroscience, immunology, biochemistry, drug discovery and RNA therapeutics,” said Scientific Director Patrick Griffin, Ph.D.
Viruses infect cells with a goal of taking control to churn out new viral copies. Cells have learned to fight back.
A new study in Nature that finds a gene therapy against HIV given at birth can protect breastfeeding babies from infection with a single dose.
One in five of our faculty holds a prestigious R35 Outstanding Investigator Award from the National Institutes of Health.
Scripps Research awarded doctoral degrees to 59 graduate students, including eight from its partner program based at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, during its 32nd commencement.
The granting of tenure signifies that scientists have made a series of substantive and creative contributions to their field of study, and demonstrated a high likelihood of continued excellence and increasing research productivity.
Two new studies show preterm births and obesity-related liver disease both improve after treatment with this antibody.
Ten graduate students who completed their doctoral studies on The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology campus in Jupiter were honored today, Friday, May 19, during Scripps Research’s 31st Commencement Ceremony in La Jolla, California. Hosted by the Skaggs Graduate School…
It was the first major scientific conference at the institute since the pandemic began, and so researchers relished the opportunity to share recent work and reconnect.
The protein called p32 might provide a potential target for drugs that keep HIV dormant and harmless. It was discovered by Susana Valente, Ph.D.
